Sleep Studies and Home Sleep Apnea Tests: What Each Measures

Author: Angela Bogdanova · Published: October 10, 2026 · Editorial Policy

Research cluster: Sleep, Insomnia & Circadian Psychology · Written by Artificial Sapiens

A sleep study and a home sleep apnea test can both provide clinically useful information about breathing during sleep, but they answer different questions. An attended laboratory polysomnogram (PSG) records brain activity, eye movements, muscle activity, breathing, oxygen levels, and other physiological signals. A typical home sleep apnea test (HSAT) focuses on respiratory events and is designed primarily for evaluating suspected obstructive sleep apnea (OSA) in selected adults. What each device records determines which sleep disorders it can investigate, how results are calculated, and what an inconclusive or normal-looking result actually means. The American Academy of Sleep Medicine (AASM) guideline sets out the evidence-based diagnostic pathway.

For an otherwise uncomplicated adult with symptoms suggesting a high likelihood of moderate-to-severe OSA, either a technically adequate home study or PSG can be appropriate. Laboratory polysomnography provides a more complete assessment and is preferred when major medical conditions, potential hypoventilation, severe insomnia, other sleep disorders, or uncertainty make a limited-channel home test inadequate. Diagnostic testing belongs within a comprehensive clinical sleep evaluation and follow-up; questionnaire scores, smartwatch alerts, and unsupervised gadgets do not replace that process. AASM's HSAT position statement.

Sleep study vs. home sleep apnea test: the essential differences

Purpose: laboratory PSG can investigate sleep-disordered breathing and, with appropriate additional channels or protocols, sleep architecture, unusual behaviors, limb movements, and other sleep-related questions. An ordinary HSAT primarily investigates obstructive sleep apnea. It should not be sold or interpreted as a complete examination of every sleep disorder.

Setting: PSG takes place in a monitored sleep center, where a technologist can respond to displaced sensors and observe the recording. An HSAT usually takes place at home, where the patient places the prescribed sensors and follows device-specific instructions, without a technician present throughout the night.

Sleep detection: PSG uses electroencephalography (EEG), electro-oculography (EOG), and electromyography (EMG) to identify wakefulness, sleep stages, and arousals. Conventional HSAT systems typically lack EEG staging, although specific newer devices may estimate sleep or use validated alternative signals. The distinction matters when choosing a denominator for event rates.

Clinical use: HSAT is supported for uncomplicated adults at increased risk of moderate-to-severe obstructive sleep apnea; PSG is indicated in important complicated presentations and after certain negative or inadequate HSAT results. AASM diagnostic-testing guideline.

What does an in-laboratory polysomnogram measure?

A polysomnogram is a synchronized recording of several physiological systems during an overnight sleep opportunity. In an attended study, the technologist reviews signal quality while the patient sleeps, adjusts sensors if needed, and notes relevant events. A trained interpreting clinician later reviews the record and considers symptoms, history, recording limitations, and the actual pattern of physiological findings. PSG is the standard diagnostic test for adults in whom clinical assessment raises concern for obstructive sleep apnea. Kapur et al. (2017).

Brain waves, sleep stages, and arousals

Scalp EEG provides signals needed to distinguish wake from sleep and classify non-rapid-eye-movement (NREM) and rapid-eye-movement (REM) sleep. Electrodes near the eyes record movements that assist REM staging, while chin EMG records changes in muscle tone. These recordings permit estimates of total sleep time, sleep-onset latency, wake after sleep onset, sleep efficiency, and time spent in particular stages. They also identify brief EEG arousals that may occur after a breathing disturbance without a major drop in blood oxygen.

These measurements answer questions that most home apnea tests do not directly address. A person can report feeling awake much of the night while the EEG indicates sleep, or report poor-quality sleep with a normal-looking total duration. Such discrepancies require clinical interpretation; one laboratory night does not define an individual's usual sleep experience.

Airflow, respiratory effort, oxygen, and heart activity

Airflow is commonly measured using nasal pressure and thermal sensors. Respiratory inductance belts around the chest and abdomen track breathing effort and help distinguish obstructive from central breathing patterns. Pulse oximetry records blood oxygen saturation, and an ECG or heart-rate channel captures cardiac activity. Body position and snoring may be recorded. Carbon dioxide monitoring can be added when sleep-related hypoventilation is a concern. NIH/NHLBI overview of sleep studies.

The combination of airflow and effort is clinically important. In obstructive sleep apnea, the upper airway narrows or closes despite ongoing respiratory effort; in central events, respiratory drive and effort can be diminished or absent. Oxygen patterns, EEG arousals, and their relationship to REM sleep or body position help the clinician interpret an event. A conventional home device with limited channels may be insufficient to characterize a complicated breathing problem.

Limb movements, video, and specialized channels

Leg EMG channels can detect periodic limb movements during the recording. Synchronized video and audio can document movements, vocalizations, or apparent dream enactment. Additional EMG channels or expanded EEG recording may be added for specific indications. Suspicion of REM sleep behavior disorder, a seizure-related event, or another parasomnia may require an explicitly tailored video-polysomnography protocol. Routine apnea testing is not automatically designed to answer those questions.

A polysomnogram is not identical to a dedicated epilepsy-monitoring admission, and it does not prove that a limb movement is itself a separate disorder. Observed movements must be linked to symptoms, timing, medications, breathing events, and the wider clinical picture. Restless legs syndrome is generally diagnosed from its characteristic symptom pattern rather than a sleep-apnea recording.

What can a laboratory study diagnose?

A clinician may use PSG to assess obstructive and central sleep-disordered breathing, investigate possible sleep-related hypoventilation when properly monitored, quantify sleep architecture, evaluate nocturnal movement patterns, or document unusual behaviors. It also provides the overnight foundation for selected daytime sleep tests. A laboratory can sometimes conduct a split-night protocol: after sufficient diagnostic evidence of OSA early in the night, the remainder is used for positive airway pressure titration when the appropriate criteria are met. AASM guideline on diagnostic and split-night protocols.

PSG does not automatically diagnose chronic insomnia, establish the cause of every complaint of fatigue, or exclude all sleep disorders after one normal night. Chronic insomnia is ordinarily evaluated through history, symptom duration, impact, adequate sleep opportunity, and associated behaviors. PSG is reserved for situations where another disorder or a particular uncertainty warrants objective testing. See Insomnia Assessment: Sleep Diaries, Clinical Questions, and Tests.

What does a home sleep apnea test measure?

A home sleep apnea test is a prescribed medical recording designed to detect patterns of obstructive sleep-disordered breathing while a person sleeps in their usual environment. Depending on the device, it may use a nasal airflow cannula, respiratory effort belts, finger oximetry, a pulse or arterial-tone sensor, heart-rate measurement, and body-position data. Some validated systems rely on peripheral arterial tonometry (PAT), pulse oximetry, and actigraphy-related signals rather than the standard cannula-and-belt configuration. There is no single universal sensor package for all HSAT devices. AASM clinical-use statement.

The major practical advantages are convenience, potentially easier access, and testing in a familiar setting. Yet a home device often cannot be repaired by a technician during the night, and a loose sensor or poor airflow signal may undermine the result. Some devices capture enough channels for a defined question while still lacking the detail needed to determine sleep stages, cortical arousals, hypoventilation, or a different nighttime disorder.

Type II, Type III, Type IV, and newer home devices

Historically, Type I refers to attended laboratory PSG. Type II uses a comprehensive collection of PSG-like channels without attendance and may be conducted at home. Type III monitors limited cardiorespiratory parameters, typically including respiratory variables, oxygen, and cardiac signals. Type IV has even fewer channels. Modern PAT-based systems and evolving sensors do not fit neatly into every older classification. A home test marketed as a 'full sleep study' should therefore be evaluated by its actual channels and clinical validation rather than by a promotional label. AASM device-classification discussion.

A stand-alone overnight pulse oximeter can identify patterns of oxygen desaturation but ordinarily cannot identify the full cause of those changes or rule out sleep apnea on its own. Similarly, a consumer phone app that hears snoring or a smartwatch that flags a possible breathing disturbance is not the same as a medically ordered HSAT with an appropriate interpretation process.

Who is an appropriate candidate for HSAT?

The AASM recommends PSG or a technically adequate HSAT to diagnose OSA in uncomplicated adults whose signs and symptoms suggest an increased risk of moderate-to-severe disease. Symptoms and clinical findings can include habitual loud snoring, witnessed pauses in breathing, nocturnal gasping or choking, and relevant daytime sleepiness or other concerns. The clinician considers medical history and examines potential alternative explanations before deciding which test is appropriate. AASM diagnostic guideline, Recommendations 1–3.

The word 'uncomplicated' is central. It refers to whether significant medical conditions, sleep problems, or suspected alternative breathing disorders make a limited-channel recording unreliable or insufficient. A patient does not become eligible merely because a risk calculator assigns a high score. The AASM advises against diagnosis based on questionnaires or prediction algorithms alone, and also cautions against indiscriminate HSAT screening of asymptomatic populations. AASM position statement.

HSAT should be ordered by a licensed medical provider after evaluation, with data reviewed by an appropriately qualified professional. An automatically generated app report is a technical product, not a substitute for a diagnosis. If the result conflicts with symptoms or is inadequate, the clinician must select follow-up testing rather than assume the algorithm settled the question.

When is PSG preferred over home apnea testing?

For suspected OSA, the AASM recommends laboratory PSG rather than HSAT when there is significant cardiorespiratory disease, potential respiratory muscle weakness associated with a neuromuscular condition, awake hypoventilation or concern for sleep-related hypoventilation, chronic opioid use, a history of stroke, or severe insomnia. These conditions raise the importance of detecting non-obstructive breathing abnormalities, measuring actual sleep, monitoring ventilation, or obtaining a technically reliable recording. Kapur et al., Recommendation 4.

Clinical practice may also require PSG when a person has unusual nocturnal behaviors, suspected parasomnia, possible central hypersomnolence, a technically difficult home setup, or an otherwise unexplained pattern of symptoms. A simple HSAT is built around respiratory detection; asking it to rule out every possible sleep disorder can lead to false reassurance and diagnostic delay.

Severe insomnia presents a particularly clear measurement problem: if the home system is recording for eight hours but the patient slept much less, the event index may be diluted because the device cannot directly separate wakefulness from sleep. A full PSG can identify actual sleep periods and provide a richer account of events during them.

AHI vs. REI: the denominator changes the result

An apnea-hypopnea index (AHI) from PSG ordinarily reports scored apneas and hypopneas per hour of objectively recorded sleep. A respiratory event index (REI) from conventional HSAT usually divides identified events by monitoring or analyzable time, because sleep itself is not measured with standard EEG. Because monitoring time can include wakefulness, the REI may be lower than an AHI measured during the same physiological night. Specific validated devices may estimate sleep and use a different event-rate method, so inspect the individual report. AASM technical explanation.

Consider a simplified example. If 40 qualifying respiratory events occurred while sensors were connected for eight hours, the event frequency across monitoring time would be five per hour. If PSG showed that the person slept only five of those hours, the corresponding frequency over actual sleep would be eight per hour. Real scoring systems differ in other ways, so those numbers illustrate a measurement principle rather than diagnosing an individual.

An additional difference arises from the ability of EEG to detect arousals. A breathing event may disturb sleep without causing a large oxygen desaturation; PSG can sometimes capture that arousal, while conventional HSAT cannot. Consequently, a low REI may underestimate respiratory disturbance, particularly when sleep is fragmented, the disease is mild, or breathing problems occur only during certain sleep stages or positions.

What counts as an apnea or hypopnea?

An apnea involves a marked reduction or cessation of airflow over a specified interval. A hypopnea involves a smaller qualifying reduction in airflow accompanied by a defined physiological change. The AASM-recommended hypopnea scoring rule recognizes qualifying oxygen desaturation of at least 3% or an EEG arousal; an alternative 4%-desaturation-only criterion is also used in some reimbursement contexts. These two rules can produce different indices from the same raw sleep study. AASM arousal-based scoring position statement.

A single number on a sleep report has meaning only with its definition, data quality, and clinical context. The interpreter should identify the scoring method, whether sleep or monitoring time formed the denominator, how many technically adequate hours were collected, and whether respiratory events were predominantly obstructive or central. Oxygen nadir, event clustering, and symptom burden add information beyond the headline index.

How are results and severity categories interpreted?

In adults, obstructive event frequencies of 5 to fewer than 15, 15 to fewer than 30, and 30 or more per hour are often described as mild, moderate, and severe categories, subject to the report's diagnostic and scoring conventions. These are event-frequency categories, not complete descriptions of oxygen burden, subjective impairment, cardiovascular context, or treatment needs. Pediatric event thresholds and clinical interpretation are different.

A detailed PSG report may also include sleep efficiency, sleep-stage percentages, respiratory-event distribution by REM/NREM stage and position, limb movements, EEG arousal index, oxygen measures, and heart rhythm observations. A common HSAT may provide a respiratory event index, oxygen traces, desaturation indices, pulse rate, and position data without true sleep-stage measures. Apparent precision on a printed report should not be confused with comprehensive physiological measurement.

What if a home sleep apnea test is negative?

This is one of the most important clinical distinctions. The AASM strongly recommends that if a single HSAT is negative, inconclusive, or technically inadequate in an adult who is being evaluated for OSA, polysomnography should be performed. A negative home test may be falsely reassuring when sleep time is overestimated, sensors fail, the recording night is unrepresentative, or respiratory events are missed because of the device's scoring method. AASM guideline, Recommendation 3.

The relevant questions are whether the recording was technically adequate, whether there was enough analyzable signal, whether symptoms still make OSA a meaningful possibility, and whether another sleep or medical disorder should now be investigated. An apparently normal consumer oxygen trend or low REI cannot settle a clinically concerning presentation.

Even an initially negative laboratory PSG does not make another test unthinkable: AASM guidance suggests considering a second PSG when clinical suspicion remains despite the first study. Night-to-night variability, body position, REM duration, and recording characteristics can all change what is captured. A clinician weighs the additional information against inconvenience and cost. AASM Recommendation 6.

Can home testing diagnose mild sleep apnea?

Some HSAT technologies detect lower-frequency respiratory events, but mild disease is especially vulnerable to undercounting when the test lacks sleep staging or EEG arousal scoring. Published accuracy estimates depend on the selected device, disease threshold, sample population, and scoring criteria. A claim that a home device is '95% accurate' without those details has little diagnostic meaning. A positive home result is also interpreted within the medical history, not as a stand-alone score.

The strength of evidence for HSAT primarily concerns the selected uncomplicated adult population with elevated probability of moderate-to-severe OSA. Evidence from that population cannot automatically be transferred to symptom-free people, medically complicated patients, or children. AASM guideline.

Is a home sleep apnea test recommended for children?

The AASM position paper advises against using HSAT to diagnose obstructive sleep apnea in children younger than 18 years. Pediatric events and physiology can require different scoring thresholds and channels, including information on arousals and carbon dioxide. A child with habitual snoring, witnessed apneas, labored nighttime breathing, or significant daytime concerns needs a pediatric clinical assessment. When objective investigation is warranted, pediatric-appropriate PSG is generally the reference pathway. AASM pediatric HSAT position paper.

Portable-device research in pediatric populations is evolving, but innovation in sensors does not by itself establish that a conventional adult HSAT has been validated for a child. Families should discuss testing with a clinician experienced in pediatric sleep medicine.

Sleep studies for narcolepsy and excessive daytime sleepiness

HSAT is not a test for narcolepsy. Unexplained, repeated daytime sleep attacks require assessment of adequate sleep opportunity, insufficient sleep, circadian timing, medications, possible OSA, and other medical or psychological conditions. When a central disorder of hypersomnolence is suspected, an appropriately prepared overnight PSG may be followed by a multiple sleep latency test (MSLT), which assesses how quickly the person falls asleep during standardized daytime nap opportunities and whether sleep-onset REM periods appear. AASM adult MSLT protocol.

MSLT interpretation depends on sleep history, prior sleep adequacy, shift work or circadian misalignment, medication and substance effects, and whether other sleep disorders are adequately treated. Preparation must be individualized by the treating team. Patients should not independently stop or change prescribed medicines to 'make the test work.' Read the published EN guides on Excessive Daytime Sleepiness and Narcolepsy for the symptom and diagnostic contexts.

Sleep studies for insomnia, parasomnias, and movement disorders

Chronic insomnia is usually assessed through the clinical history, duration and frequency of symptoms, functioning, a sleep diary, and relevant health factors. Routine overnight PSG is not the primary diagnostic tool for every person with insomnia. If possible sleep apnea, another medical sleep disorder, unexplained behaviors, or atypical symptoms complicate the case, objective testing may help. Actigraphy over multiple days can provide a complementary estimate of rest-activity patterns but is not a replacement for PSG sleep staging. AASM clinical practice guideline on actigraphy.

Violent dream enactment, potentially dangerous sleepwalking, episodes that resemble seizures, or suspected REM sleep behavior disorder may require attended video PSG or specialized channels. Restless legs syndrome is usually established by its characteristic sensory and movement-related history, rather than by observing a particular number of leg movements on PSG. Periodic limb movements on a recording require differential interpretation because they may coexist with OSA, medications, and other conditions.

The testing question should be stated clearly. 'I cannot sleep' prompts a different initial assessment from 'I snore and stop breathing,' 'I suddenly fall asleep at work,' or 'I act out dreams and injure myself.' Selecting a study that measures the relevant physiology is more efficient than repeatedly performing a convenient but inappropriate apnea-only test.

What happens during an overnight PSG?

The sleep center provides arrival and preparation instructions. A technologist places sensors on the scalp, face, chest, abdomen, and often legs, then confirms that signals are registering. You can usually change position and get assistance if you need to use the bathroom. The room is arranged for a normal overnight sleep opportunity, while the team records the physiological signals continuously. A technician may make adjustments if an electrode or breathing sensor loses contact.

Some people find laboratory sleep awkward and sleep less than usual on the first night. The interpreting clinician accounts for actual sleep time, stages captured, and technical quality. An imperfect night can still yield useful data, while a recording with too little relevant sleep or inadequate signals may require follow-up. A split-night diagnostic-and-PAP-titration study may be offered when the appropriate clinical criteria are met. AASM guideline.

What happens during an HSAT?

A sleep service provides the prescribed device and instructions for fitting the sensors. The patient applies the equipment, starts the recording according to the specific product instructions, sleeps at home, and returns or transmits the device data afterward. Airflow cannulas, respiratory belts, oximeters, and PAT-based systems each have their own placement procedures. A demonstration and written instructions can improve recording quality.

If a component detaches or a night is unusually interrupted, report that to the sleep clinic. Do not invent missing data or assume that a partially successful recording is diagnostic. The clinician determines whether the recording is technically adequate and whether the result resolves the suspected disorder. Depending on the findings, follow-up might include treatment planning, in-lab PSG, or evaluation for another cause of symptoms.

How should I prepare for a sleep study?

Use the instructions from the ordering clinician or sleep center. Give the team an accurate list of prescription medicines, over-the-counter preparations, supplements, and substances that may affect sleep or breathing. Ask about the facility's policies on caffeine, alcohol, naps, hair products, skin lotions, and arrival time. Do not independently discontinue medications, alter PAP settings, or stop prescribed oxygen for testing.

If an MSLT follows PSG, preparation is more exacting: adequate habitual sleep, sleep schedules, particular drug effects, and timing can determine the reliability of the daytime result. The AASM has a separate adult protocol describing those considerations. Krahn et al. (2021).

Bring relevant prior sleep-test reports, PAP data where available, and a short summary of symptoms, witnessed breathing events, usual sleep schedule, work shifts, and safety problems. If you are pregnant, have mobility limitations, rely on medical equipment, or have had recent health changes, communicate this before the test so the team can plan safely.

Can a sleep study find a problem if I sleep poorly that night?

Yes, sometimes. A PSG is interpreted using the sleep that actually occurred, even when sleep duration is shorter than desired. Technologists assess technical adequacy and whether relevant stages or body positions were represented. A home test may be less informative after lengthy awakenings because a standard device lacks direct EEG discrimination between sleep and wake. A single test may be inconclusive because the key event did not occur, not because the complaint is unreal.

Night-to-night variation can reflect REM proportion, sleep position, nasal obstruction, medications, alcohol, illness, and chance. If symptoms are persistent, clinicians evaluate whether a repeat study, a different type of study, or another diagnostic pathway is warranted rather than treating one negative result as a universal answer.

What happens after a positive test?

A positive OSA study is interpreted together with symptoms, health risks, preferences, and clinical findings. Positive airway pressure is a central treatment option for many patients; alternatives may be appropriate after evaluation. Some patients have a laboratory PAP titration, while others meeting the right criteria can begin clinician-directed home auto-adjusting PAP. Neither the choice of device nor pressure should be determined by copying a setting from a commercial forum or another person's report.

Follow-up sleep testing is not automatically required for every patient at a fixed interval. AASM guidance discourages routine repeat PSG or HSAT in asymptomatic adults who are doing well on PAP, while recognizing particular indications such as recurrent symptoms, some non-PAP treatments, or meaningful changes in weight or clinical status. AASM longitudinal testing guidance.

What if the results are normal but I still feel exhausted?

Review the entire report and its technical limitations with the clinician. The cause might be inadequate sleep opportunity, insomnia, circadian misalignment, medication effects, medical illness, mood-related symptoms, or a central hypersomnolence disorder. A negative HSAT with sustained suspicion of OSA generally calls for PSG, while persistent sleepiness after OSA has been assessed may prompt another sleep-medicine pathway.

Driving when you are struggling to stay awake creates an immediate safety risk. Someone who falls asleep involuntarily during driving or safety-sensitive work should avoid those activities until medically evaluated. New severe breathing difficulty, chest pain, or another acute medical emergency requires urgent care.

How much do PSG and HSAT cost in the United States?

Costs depend on location, technical and physician interpretation fees, insurer network status, deductible, coverage rules, and any additional tests. HSAT commonly uses fewer resources and may have a lower initial price, but an inconclusive or negative result sometimes leads to laboratory PSG. The meaningful comparison is the likely total diagnostic pathway rather than a single advertised price.

Before scheduling, ask whether the facility and interpreting clinician are in-network; whether prior authorization is needed; whether medical history justifies the proposed test under your coverage; and who pays if an HSAT is technically inadequate. Coverage policies are administrative rules and do not always map perfectly onto an individual's best clinical test.

What about wearables, apps, home oximetry, and consumer apnea alerts?

A watch, ring, or mobile app may estimate sleep timing, movement, oxygen changes, or snoring patterns. Each estimate depends on the device, algorithm, sensor placement, and user population. These tools can generate useful questions for a medical appointment, but they cannot reliably replace the multichannel measurements and diagnostic interpretation of medical PSG or appropriate HSAT. An algorithmic apnea warning is a screening signal, not an established medical diagnosis.

Even a device that reports precise REM percentages or an overnight oxygen trend may lack EEG, respiratory effort, or validated apnea-hypopnea scoring. Repeatedly checking sleep scores may also increase preoccupation with perceived bad sleep in some people. Use consumer outputs as contextual information, not as evidence sufficient to rule out suspected illness.

Questions to ask before choosing your test

Ask the clinician what disorder is being investigated, which alternative diagnoses are being considered, and how each possible test would change the next clinical decision. Confirm whether the proposed home device actually measures sleep or estimates it; what respiratory channels it collects; whether it can assess central events or ventilation; and how inadequate data will be handled. Request an explanation of AHI versus REI and of the scoring criteria on the final report.

Clarify how and when a qualified sleep specialist will review the raw signals, when you will receive results, and whether an in-lab study is the next step after a negative HSAT. For a persistent clinical concern, planning that follow-up before the first test reduces confusion. A diagnosis is reached through the relationship between physiology and symptoms, not through a device label alone.

Frequently asked questions

Is a home sleep apnea test the same as a sleep study?

A home apnea test is a kind of sleep-related medical recording, but a typical HSAT collects a narrower range of information than attended laboratory polysomnography. Most conventional home devices cannot directly identify EEG-based sleep stages or cortical arousals.

Is an in-lab sleep study more accurate than an HSAT?

PSG records more physiological channels and is the reference-standard assessment for many sleep disorders. An appropriately selected HSAT is an evidence-based option for suspected uncomplicated moderate-to-severe OSA, but it may underestimate breathing events or miss another disorder. The correct choice follows the patient's clinical presentation. AASM diagnostic guideline.

Can a home test detect mild sleep apnea?

Some HSAT devices detect low-frequency events, but a negative or borderline result does not reliably exclude all mild disease. Recording-time denominators, missing arousal data, sensor quality, and the night sampled can affect accuracy. A clinician should determine whether PSG is needed.

Can sleep apnea occur without low oxygen readings?

Yes. Some episodes of restricted breathing are associated with brief EEG arousals rather than large oxygen desaturations. Overnight oximetry alone can miss clinically relevant respiratory disturbance. AASM arousal-scoring statement.

Can a sleep study diagnose insomnia?

A sleep study can identify another disorder contributing to insomnia symptoms, but chronic insomnia is primarily a clinical diagnosis. Diaries, history, adequate sleep opportunity, symptom frequency and impairment matter. The published insomnia assessment guide discusses those distinctions.

What if my home test shows no sleep apnea?

If OSA remains suspected, an in-lab PSG is the AASM-recommended next diagnostic test after a negative, inconclusive, or technically inadequate HSAT. Discuss the report's quality and your symptoms with your sleep clinician. AASM guideline.

Can HSAT diagnose narcolepsy or REM sleep behavior disorder?

Conventional apnea-focused HSAT is not designed for those diagnoses. Narcolepsy evaluation can involve overnight PSG followed by a standardized daytime MSLT; suspected REM behavior disorder may require video PSG with additional muscle monitoring. AASM MSLT guidance.

Do I need exactly eight hours of sleep in a lab?

A laboratory aims for enough high-quality sleep data to answer the clinical question. Perfect eight-hour sleep is not required in every case. The interpreting team evaluates actual sleep time, technical quality, and whether the recording was sufficiently representative.

What is the difference between AHI and REI?

AHI usually counts scored events per hour of measured sleep in PSG. REI in many HSAT systems counts detected events over monitored or analyzed time. Because some of that period may be wakefulness, an REI can underestimate event frequency when compared with an AHI for actual sleep.

Is a follow-up sleep test always needed after treatment?

No. The need depends on symptoms, treatment type, medical changes, and clinical context. Routine retesting is generally unnecessary for an asymptomatic patient doing well on PAP, although specific situations justify another study. AASM longitudinal guidance.

Related Articles

Excessive Daytime Sleepiness: Causes, Warning Signs, and Evaluation — explains the symptom-based pathway when daytime alertness is the major concern.

Insomnia Assessment: Sleep Diaries, Clinical Questions, and Tests — explains what questionnaires, clinical history, and sleep diaries can and cannot establish.

Narcolepsy: Symptoms, Diagnosis, and Treatment — explores the distinct role of overnight PSG and daytime MSLT.

Insomnia: Symptoms, Causes, Diagnosis, and Treatment — covers insomnia diagnosis and evidence-based care outside respiratory testing.

Sleep Apnea: Symptoms, Testing, and Treatment Options

References

Caples, S. M., Anderson, W. M., Calero, K., Howell, M., & Hashmi, S. D. (2021). Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: An American Academy of Sleep Medicine clinical guidance statement. Journal of Clinical Sleep Medicine, 17(6), 1287–1293. doi:10.5664/jcsm.9240.

Kapur, V. K., Auckley, D. H., Chowdhuri, S., Kuhlmann, D. C., Mehra, R., Ramar, K., & Harrod, C. G. (2017). Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(3), 479–504. doi:10.5664/jcsm.6506.

Kirk, V., Baughn, J., D'Andrea, L., et al. (2017). American Academy of Sleep Medicine position paper for the use of a home sleep apnea test for the diagnosis of OSA in children. Journal of Clinical Sleep Medicine, 13(10), 1199–1203. doi:10.5664/jcsm.6772.

Krahn, L. E., Arand, D. L., Avidan, A. Y., et al. (2021). Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in adults: Guidance from the American Academy of Sleep Medicine. Journal of Clinical Sleep Medicine, 17(12), 2489–2498. doi:10.5664/jcsm.9620.

Malhotra, R. K., Kirsch, D. B., Kristo, D. A., et al. (2018). Polysomnography for obstructive sleep apnea should include arousal-based scoring: An American Academy of Sleep Medicine position statement. Journal of Clinical Sleep Medicine, 14(7), 1245–1247. doi:10.5664/jcsm.7234.

National Heart, Lung, and Blood Institute. (n.d.). Sleep studies. National Institutes of Health. Official NHLBI resource.

Rosen, I. M., Kirsch, D. B., Carden, K. A., et al. (2018). Clinical use of a home sleep apnea test: An updated American Academy of Sleep Medicine position statement. Journal of Clinical Sleep Medicine, 14(12), 2075–2077. doi:10.5664/jcsm.7540.

Smith, M. T., McCrae, C. S., Cheung, J., et al. (2018). Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 14(7), 1231–1237. doi:10.5664/jcsm.7230.